Acyclic analogues of 5-fluoro-dUMP and 5-fluoro-2'-deoxyuridine: Synthesis and inhibition of thymidylate synthase and tumour cell growth

• Autorzy: Felczak K. , Golos B. , Dzik J. , Rode W. , Bretner M. , Shugar D. , Kulikowski T.
• Języki publikacji: EN

Abstrakty

EN

1-[(2-Hydroxyethoxy)methyl]-5-fluorouracil (HEMFU) and 1-[(1,3-dihydroxy-2-propoxy)methyl]-5-fluorouracil (DHPFU) were prepared by alkylation of the di-O-TMS derivative of 5-fluorouracil and phosphorylated with the use of the wheat shoot phosphotransferase system to their monophosphates, HEMFUMP and DHPFUMP. 1-(2-Phosphonylmethoxyethyl)-5-fluorouracil (PMEFU) was obtained by condensation of diethyl-2-chloroethoxymethanephosphonate with 5-fluorouracil and cleavage of the alkylphosphoester with trimethylbromosilane. Inhibition of highly purified thymidylate synthase from mouse tumour Ehrlich carcinoma and leukemia L1210 cells by each of the nucleotide analogues, DHPFUMP, PMEFU and HEMFUMP, and of L5178Y mouse leukemia cell growth by the nucleoside (HEMFU) analogue, were studied. DHPFUMP proved to be the strongest inhibitor, non-competitive vs dUMP, with Kiapp 2.8 μM for time-independent interaction with the enzyme and N5,N10-methylenetetrahydrofolate (CH2H4PteGlu). In the presence of CH2H4PteGlu, DHPFUMP exhibited time-dependent inactivation of the enzyme, the inactivation rate plots being biphasic and pointing to Ki values in the μM range (103-fold higher than for 5-fluoro-dUMP). HEMFUMP and PMEFU were much weaker inhibitors of the enzyme, with Kiapp values of 0.26 μM (non-competitive vs dUMP) and 30 mM (non-competitive vs dUMP), respectively. HEMFU, despite the weak interaction of its nucleotide analogue with the enzyme, proved to be a strong cell (L5178Y) growth inhibitor, with IC50 in the range 10-5 M.

Słowa kluczowe

EN

cell growth; 5-fluoro-2'-deoxyuridine; tumour cell; 1-[[1,3-dihydroxy-2-propoxy]methyl]-5-fluorouracil; acyclic nucleotide; thymidylate synthase; antitumour activity; 1-[[2-hydroxyethoxy]methyl]-5-fluorouracil; acyclic nucleoside; monophosphate

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 1998
• Tom: 45
• Numer: 1
• Opis fizyczny: p.75-82,fig.

Twórcy

autor

Felczak K.

• Polish Academy of Sciences, A.Pawinskiego 5a, 02-106 Warsaw, Poland

autor

Golos B.

autor

Dzik J.

autor

Rode W.

autor

Bretner M.

autor

Shugar D.

autor

Kulikowski T.

Bibliografia

• 1. Naesens, L., Snoeck, R.t Andrei, G., Balzarini. J., Neyts, J. & De Clercq, E. (1996) HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues: A review of their pharma­cology and clinical potential in the treatment of vi­ral infections. Antiviral Chem. Chemother. 8,1-23.
• 2. Holy, A., Rosenberg, I. & Dvorakova, H. (1989) Syn­thesis of (3-hydroxy-2phosphonylmethoxypropyl) derivatives Df heterocyclic bases. Collect. Czech. Chem. Commun, 54, 2470-2501.
• 3. Kelley, J.L., Kelsey, J.E., Hall, W.R., Krochmal, M.P. & Schaeffer, H.J. (1981) l-[(2-Hydroxy- ethoxy)methyll pyrimidines as candidate antivirals. J. Med. Chem. 24. 753-756.
• 4. Rosowsky, A., Kim, S.-H. & Wick, M. (1981) Synthe­sis and antitimor activity of an acyclonucleoside de­rivative of 5-fluorouracil. J. Med. Chem. 24, 1177- 1181.
• 5. Chen, P.S., Toribara, T.Y. & Warner. H. (1956) Mi- crodetermination of phosphorus. Anal Chem. 28, 1756-1758.
• 6. Ubasawa, M., Takashima, H. & Sekiya, K. (1995) A convenient one-pot synthesis of acyclonucleosides. Chem. Pharm. Bull. 43, 142-143.
• 7. Robins, M.J. & Hatfield, P.W. (1982) Nu­cleic acid related compounds. 37. Con­venient and high-yield syntheses of iV-f(2- hydroxyethoxy)methyll heterocycles as "acyclic nucleoside" analogues, Can. J. Chem. 60, 547-553.
• 8. Giziewicz, J. & Shugar, D. (1978) Enzy­matic phosphorylation of nucleosides to the 5' phosphates; in Nucleic Acid Chemis­try (Townsed, L.B. & Tipson, R.S., eds.) pp. 955-961, John Wiley, New York.
• 9. Ogilvie, K.K., Hamilton, R.G., Gillen, M.F., Radatus, B.K., Smith, K.O. & Gol- loway, K.S. (1984) Uracil analogues of the acyclonucleoside 9-([(2-hydroxy-l- hydroxymethyl)ethoxyJ-methyl]guanine (BIOLF-62). Can. J. Chem. 62, 16-21.
• 10. Scheit, K.H. & Faerber, P. (1978) The synthesis of pyrimidinethione nucleo­side 5'-mono-, -d»-, -tri phosphates; in Nu­cleic Acid Chemistry (Townsed, L.B. & Tipson, R.S., eds.) pp. 793-799, John Wiley, New York.
• 11. Hayes, S.J. & Lis, A.W. (1971) Studies on 5-hydroxyuridine (isobarbituridine): IV. Corre­lation of the spectral properties of i>- hydroxyuridine and its N- and 0- methyl de­rivatives. Physiol. Chem, & Physics 3,205-225.
• 12. Rode, W., Zieliński, Z., Dzik, J.M., Kulikowski, T.f Bretner, M., Kierdaszuk, B., Cieśla, J. & Shugar, D. (1990) Mechanism of inhibition of mammalian tumor and other thymidylate syn­thases by A^-hydroxy-dCMP, A^-hydroxy-S- fluoro-dCMP, and related analogues. Biochem­istry 29, 10835-10842.
• 13. Dzik, J.M., Bretner, M., Kulikowski, T., Golos, B., Jarmula, A., Poznanski, J., Rode, W. & Shugar, D. (1996) Synthesis and interactions with thymidylate synthase of 2,4 dithio ana­logues of dUMP and 5-fluonKlUMP. Biûchim. Biophys Acta 1293, 1-8.
• 14. Campos, J., Pineda, M.J., Gómez, J.A., En­trena, A., Trujillo, M.A., Gallo, M.A. & Espi­nosa, A. (1996) 5-Fluorouracil derivatives. 1. Acyclonucleosides through a tin (IV) chloride- mediated regiospecific ring opening of alkoxy- 1,4-diheteroepanes. Tetrahedron 52, 8907- 8924.
• 15. Gómez, J.A., Campos, J., Marchai, J.A., Tru­jillo, M.A., Melguizo, C., Prados, J., Gallo, M. A., Arnega, A. & Espinosa, A. (1997) Chemi­cal modifications on the acyclic moiety of 3-{2- hydroxyethoxy)l-alkoxypropyl nucleobases. 2. Differentiation and growth inhibition in Rhab- domyo sarcoma cells after exposure to a novel 5-fluorouracil acyclonucleoside. Tetrahedron 53, 7319-7334.